Streetbeat News

Earnings

AREC

American Resources Corporation (NASDAQ: AREC) is scheduled to release its quarterly earnings report on November 14, 2023. Analysts predict an EPS of $-0.14. Investors are looking for an earnings beat and positive guidance for future growth. Historical data shows that the company's stock price is significantly affected by earnings performance and guidance. Last quarter, AREC missed EPS estimates by $0.05, resulting in a 22.41% share price drop the following day. Over the past year, AREC shares have declined by 27.37%, indicating potential dissatisfaction among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:01 pm

SGBX

Safe & Green Holdings (NASDAQ:SGBX) is scheduled to release its quarterly earnings report on November 14, 2023. Analysts predict an EPS of $-0.36. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, SGBX's stock price has been sensitive to earnings performance and guidance. Last quarter, the company missed EPS estimates by $0.14, resulting in a 1.33% share price drop the following day. Over the past year, SGBX shares have declined by 19.19%.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:01 pm

JAGX

Jaguar Health (NASDAQ:JAGX) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-1.23. Investors are looking for an earnings beat and positive guidance for the next quarter. Jaguar Health's stock performance has been negative over the last 52-week period, with shares down 97.14%. The company's past earnings performance has not consistently impacted its stock price post-earnings.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:01 pm

NDRA

ENDRA Life Sciences (NASDAQ:NDRA) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-0.43. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, NDRA's stock price has been volatile post-earnings, with a mix of positive and negative reactions. The stock is currently trading at $0.954, down 76.92% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:01 pm

ONTX

Onconova Therapeutics (NASDAQ:ONTX) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-0.29. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has reacted negatively to past earnings reports, even when beating EPS estimates. Shares are currently trading at $0.64, down 22.3% over the last 52 weeks, indicating general dissatisfaction among long-term shareholders.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:01 pm

TIVC

Tivic Health Systems, Inc. (NASDAQ:TIVC) shares surged on heavy trading volume ahead of its Q3 financial results report, despite no company-specific news. The company is expected to report a loss of $7.00 per share and revenue of $780 thousand. Tivic Health Systems is a health technology company with its first commercial product, ClearUP Sinus Relief, designed for non-invasive sinus pain and congestion relief.

Portfolio Pulse from Erica Kollmann

November 13, 2023 | 4:54 pm

FTRE

Fortrea shares have seen an increase in trading after the company reported third-quarter results that surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:51 pm

MNDY

Monday.Com's stock is trading higher following the release of their Q3 results, which surpassed expectations. The company also provided a positive outlook with strong guidance for future performance.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:50 pm

CURLF

GTBIF

MRMD

PLNH

TCNNF

TRSSF

VRNOF

The recent earnings reports from eight major Multi-State Operators (MSOs) in the cannabis industry show mixed results on revenue and EBITDA, but the standout detail is the positive Cash Flow from Operations (CFFO) in Q3. Most companies beat consensus projections for CFFO, with tax deferrals being a significant driver. Investors are advised to focus on CFFO rather than revenue or EBITDA, and to distinguish between repeatable cash flows and future cash outflows due to deferred payments. The Viridian Cannabis Deal Tracker provides insights into capital raise and M&A activity in the cannabis sector.

Portfolio Pulse from Viridian Capital Advisors

November 13, 2023 | 4:47 pm

RLX

RLX Technology's stock price has increased following the announcement of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:46 pm